Monday, October 25, 2021
اُردُو نیوز Newspaper Live-TV(UK) Live-TV(PK)
اُردُو نیوز Newspaper
Live-TV(UK) Live-TV(PK)

US panel finds Sarepta muscular dystrophy drug not proven effective

US panel finds Sarepta muscular dystrophy drug not proven effective
April 26, 2016
SAN FRANCISCO - An experimental drug to treat Duchenne muscular dystrophy, a devastating degenerative disease that mostly affects young boys, was not supported by enough evidence to prove it is effective, a US advisory panel concluded, decreasing the drug's chances of approval The vote followed an emotional meeting at a hotel in Hyattsville, Maryland, in which hundreds of patients and their advocates gathered to urge the Food and Drug Administration to approve the drug, Sarepta Therapeutics Inc's eteplirsen, saying their children had benefited from it. -Reuters
تازہ ترین خبریں حاصل کرنے کے لیے فوری اطلاع کی اجازت دیں

آپ کسی بھی وقت دائیں طرف نیچے بیل آئیکن پر صرف ایک کلک کے ذریعے آسانی سے سبسکرائب کر سکتے ہیں۔